Emergent BioSolutions Inc. - SIC # 7690 -

Ticker Exchange SIC # Website Latest Ticker
EBS New York 7690 www.emergentbiosolutions.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Emergent BioSolutions Inc.

Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray - Aug 31st, 2026 5:55 am
Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day - Aug 31st, 2026 5:54 am
Emergent BioSolutions (EBS) Q2 2026 Earnings Call Transcript - Aug 12th, 2026 4:13 pm
Why Did TTD, PZZA, EBS Stocks Plummet To 52 Week Lows? - Aug 10th, 2026 10:02 pm
Emergent Biosolutions Q2 Earnings Call Highlights - Aug 7th, 2026 11:03 pm
Emergent BioSolutions Inc. Q2 2026 Earnings Call Summary - Aug 6th, 2026 6:30 am
Emergent BioSolutions Reports Second Quarter 2026 Financial Results - Aug 5th, 2026 2:07 pm
Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment - Aug 5th, 2026 2:07 pm
Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026 - Jul 22nd, 2026 2:01 pm
Erste Group Bank (WBAG:EBS) Stock Looks Undervalued As Its 384% 5 Year Run Continues - Jul 1st, 2026 7:18 am
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government - Jun 29th, 2026 7:13 am
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose - Jun 4th, 2026 6:02 am
Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy - May 28th, 2026 2:01 pm
Emergent BioSolutions Inc. (EBS) Gains Attention as ACAM2000 Receives Broader Public Health Authorization - May 20th, 2026 2:43 pm
Emergent BioSolutions to Participate in Upcoming Investor Conferences - May 20th, 2026 5:30 am
Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live] - May 18th, 2026 6:59 am
A Look At Erste Group Bank’s (WBAG:EBS) Valuation After Strong Q1 2026 Earnings And New Bond Issue - May 8th, 2026 12:19 am